Skip to Content

Galapagos NV

GLPG

Buy $GLPG at eToro
Rank 2895
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address GEN DE WITTELAAN L11 A3, 2800 MECHELEN, BE

Galapagos NV - Key figures

Market cap 3.66 Billion
Revenue 507.3 Million
Profit -8,490,000
P/E Ratio No information
P/s Ratio 7.22
Buy $GLPG at eToro

Galapagos NV - Description

Galapagos NV, a clinical-stage biotechnology company, discovers, develops and markets several small molecule drugs.

The company is headquartered in Mechelen, Belgium.